2010
DOI: 10.1016/j.transproceed.2010.03.114
|View full text |Cite
|
Sign up to set email alerts
|

Extracorporeal Circulatory Support for Lung Transplantation: Institutional Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
8
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 9 publications
1
8
0
Order By: Relevance
“…[11][12][13][14][15] Recent clinical advances have served to further increase the efficacy and safety of contemporary ECMO use as a whole. 7,16 Many centers have published improved results with ECMO, but, even collectively, these have been based on small numbers. 7,[16][17][18][19] Furthermore, the reports have had mixed conclusions resulting in equivocation and a general lack of consensus.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…[11][12][13][14][15] Recent clinical advances have served to further increase the efficacy and safety of contemporary ECMO use as a whole. 7,16 Many centers have published improved results with ECMO, but, even collectively, these have been based on small numbers. 7,[16][17][18][19] Furthermore, the reports have had mixed conclusions resulting in equivocation and a general lack of consensus.…”
mentioning
confidence: 99%
“…7,16 Many centers have published improved results with ECMO, but, even collectively, these have been based on small numbers. 7,[16][17][18][19] Furthermore, the reports have had mixed conclusions resulting in equivocation and a general lack of consensus. 3,4,7,8,[20][21][22][23][24] Nevertheless, the growing trend in recent series is invariably favorable, and supportive evidence in our own practice prompted this national analysis.…”
mentioning
confidence: 99%
“…3,4,10,11 Though open-circuit CPB and closed-circuit ECMO share the features of unloading the pulmonary circulation, minimizing intraoperative ventilator support and allowing controlled reperfusion, the clear-cut advantages of ECMO over CPB are the possibility to prolong ECMO therapy into the postoperative intensive care and, in particular, to restrict the use of heparin. 3,4,10,11 With that, the strict need for full heparinization for ECC in LuTx is put to test, as it may be a relevant perioperative risk factor. 8,9,14 The MLTG has used CPB with full heparinization for ECC during LuTx, roughly until 2012, but changed to basically only use venoarterial ECMO for ECC during LuTx.…”
Section: Discussionmentioning
confidence: 99%
“…Such situations may require the intraoperative establishment of extracorporeal circulation (ECC) devices during LuTx. [3][4][5] Traditionally, open-circuit cardiopulmonary bypass (CPB) with mandatory full heparinization is used, as it is a proven effective supportive technique. [5][6][7] However, blood conductance through the circuit activates inflammatory reactions, and the obligatory full heparinization may lead to bleeding complications and coagulation disorders, particularly in surgically complex cases, for example, redo-surgery.…”
Section: Introduction/backgroundmentioning
confidence: 99%
“…1,2 Intraoperatively, ECC helps to overcome excessive pulmonary hypertension and associated right heart failure after clamping of the pulmonary hilum or global hypoxia and hypercarbia during one lung ventilation. [3][4][5] Whereas in the past, there has been controversy about the benefit and risks of routine ECC use during lutx procedures, there is growing evidence that patients undergoing lutx on ECC support receive more blood products, have longer mechanical ventilation time, and prolonged intensive care unit (ICU) and hospital length of stay. 6 There is a higher risk of bleeding and an elevated need for re-thoracotomies in these patients.…”
mentioning
confidence: 99%